GenLumina
PrivateLast Round
Seed
Jun 17, 2025
Est. Valuation
$10.9M
Total Funding Raised
$640,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GenLumina operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Seed round in June 2025.
GenLumina is a biotechnology company developing a light-activated DNA nanomedicine platform for targeted oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenLumina Comparables
Compare GenLumina with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Covalt Bio | 83% | |
| Illuminate Therapeutics | 83% | |
| DNA Nanobots | 81% |
For institutional investors. Book with your work email.
GenLumina Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 17, 2025 | ||||
| Early Funding | Jun 13, 2025 | ||||
| Grant | Nov 6, 2024 | ||||
| Pre Seed | Aug 13, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenLumina Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Pre Seed |
| InnovationQuarter | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 88% MoM, reaching 1K.
- Jun 18, 2026
Grew 75% QoQ, from 4 to 7 employees.
For institutional investors. Book with your work email.
GenLumina Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenLumina's valuation, stock price, and market status.
Is GenLumina a public or private company?
GenLumina is a private company.
What is the current stock price of GenLumina?
GenLumina is a private company, so its shares have no public market price. Caplight tracks GenLumina's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenLumina worth (valuation)?
GenLumina's valuation is estimated at $10.9M based on funding round data.
Can I buy GenLumina stock?
GenLumina shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenLumina's last funding round?
GenLumina's most recent funding round was Seed on June 17, 2025.
Who are the main investors in GenLumina?
Key investors in GenLumina include InnovationQuarter.
Will GenLumina IPO soon?
No public IPO plans have been announced for GenLumina.
How can I track GenLumina secondary market activity?
Caplight tracks bids, offers, and trades in GenLumina's shares on secondary markets.